Gianluca Carrera

Deals

Where the value actually went.

Announced data monetisation deals and moves, each read from the data owner’s seat: who did the work, what crossed, and who kept the rake.

Entries are classified by a stated method — including the ones where the public facts do not settle it, which are published as unclear rather than guessed.

Reviewed only (30)All deals (55)

✓ Reviewed: read and analysed by Gianluca. Others are short summaries of the public record.

16 entriessell 7unclear 2n/a 1
AnnouncedDealRouteConfigurationPublished
2026-09-21AbbVie and Iambic announce multi-year AI drug discovery collaboration in immunology, neuroscience and oncologyAbbVie · Iambic Therapeutics——2026-09-30
2026-09-16MSK and OpenEvidence partner to integrate OncoKB into OpenEvidence and OpenEvidence into MSK's EpicMemorial Sloan Kettering Cancer Center · OpenEvidence——2026-09-30
2026-09-16Twist Bioscience joins Lilly TuneLab as preferred antibody characterization data providerTwist Bioscience · Eli Lilly——2026-09-30
2026-09-15Tempus AI discloses ~$200M Q2 data-licensing TCV and 36% growth at Morgan Stanley healthcare conferenceTempus AI——2026-09-30
2026-09-15Century Health and Eye Health America partner to build de-identified retinal disease RWD datasetCentury Health · Eye Health America——2026-09-30
2026-09-15Neuberger and KKR agree significant minority stake in health-data platform Datavant alongside New Mountain✓Datavant · Neuberger · KKR · New Mountain CapitalN/ANot relevant2026-09-20
2026-09-11Owkin licenses K Pro AI scientist and MOSAIC multimodal patient data to Servier for oncology research✓Owkin · ServierSellOwner-enriched2026-09-11
2026-09-11reportedMitsui signs service agreement with Oncoshot to analyse IHH oncology real-world data across Asia-Pacific✓Mitsui & Co. · Oncoshot · IHH HealthcareSellPartner-enriched, owner-fronted2026-09-11
2026-09-09Flatiron Health renews NCCN real-world oncology data collaboration through 2028, deploys Flatiron Telescope✓Flatiron Health · National Comprehensive Cancer NetworkUnclearOwner-enriched2026-09-15
2026-09-02Owkin licenses K Pro AI Scientist plus multimodal oncology and immunology patient data to Boehringer Ingelheim✓Owkin · Boehringer IngelheimSellOwner-enriched2026-09-05
2026-09-02date uncertainnference and Rush University System for Health announce long-term partnership for Rush-hosted clinical analytics platform✓nference · Rush University System for HealthUnclearPartner-enriched, owner-fronted2026-09-05
2026-07-28OneMedNet signs $11.5M+ agreement to supply regulatory-grade real-world imaging data for foundational AI model training✓OneMedNetSellBuyer-enriched2026-08-01
2026-04-09date uncertainTempus AI expands multi-year collaboration giving Gilead enterprise-wide access to Lens platform and multimodal real-world oncology data✓Tempus AI · Gilead SciencesSellOwner-enriched2026-04-09
2026-04-01reportedAnthropic's $400M acquisition of Coefficient Bio for domain-specific biotech data underscores substrate dimensions✓Anthropic · Coefficient Bio · DimensionSellUnclear2026-04-10
2026-03-03Tempus expands multi-year Merck collaboration giving Merck access to de-identified multimodal data and Lens platform✓Tempus AI · MerckSellOwner-enriched2026-03-03
2026-02-18Merck and Mayo Clinic announce R&D collaboration for AI-enabled drug discovery and precision medicineMerck · Mayo Clinic——2026-09-30

Newsletter

Each essay, by email, as it is published.

For operators, boards and investors who have to decide where value goes before the dust settles.